Comment by
stckapprentice on Jan 17, 2018 7:49am
“With the way the multiples work, Newstrike is now worth more than CanniMed,” said Jason Zandberg, an analyst with PI Financial Corp. “I believe it’s a 65, 35 merger, so (Newstrike shares) would be worth almost half in that transaction.” exactly what I said.... newstrike needs to be valued on a multiple of it's share price. Deal will fall through... load up on hip shares and ACB shares
Comment by
KingMidasAu on Jan 17, 2018 7:50am
Wasn't the vote supposed to be Friday for CMED? It got pushed back to next Tuesday now? More time for ACB to buy and lock up more CMED shares